AFP and hepatocellular carcinoma: The value of specific HCC biomarkers, such as AFP, is currently well established for the purposes of screening, prognosis and waiting list registration for liver transplantation (LT) [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17].